EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseLeitlinieOpen Access · CC BY-NC 4.0

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis

Yoichi Nakayama iD, Wataru Nagata, Yoichi Takeuchi, Sho Fukui, Yuya Fujita, Yohei Hosokawa, Masanobu Ueno, Kumiko Ono, Shuji Sumitomo, Yuya Tabuchi, Yuichiro Nakanishi, Shuntaro Saito und 24 weitere

Modern Rheumatology · 2024

DOI: 10.1093/mr/roae049 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Yoichi Nakayama und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid, Practice Guidelines as Topic, Rheumatology. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this article is to update evidence on the efficacy and safety of disease-modifying antirheumatic drugs (DMARDs) and provide information to the taskforce for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis (RA).

Methods

We searched various databases for randomised controlled trials on RA published until June 2022, with no language restriction. For each of the 15 clinical questions, two independent reviewers screened the articles, evaluated the core outcomes, and performed meta-analyses.

Results

Subcutaneous injection of methotrexate (MTX) showed similar efficacy to oral MTX in MTX-naïve RA patients. Ozoralizumab combined with MTX improved drug efficacy compared to the placebo in RA patients with inadequate response (IR) to conventional synthetic DMARD (csDMARD). Rituximab with and without concomitant csDMARDs showed similar efficacy to other biological DMARDs (bDMARDs) in bDMARD-IR RA patients. Combined Janus kinase inhibitors and MTX achieved similar clinical responses and equal safety during a 4-year period compared to tumour necrosis factor inhibitors in MTX-IR RA patients. Biosimilars showed efficacy equivalent to that of the original bDMARDs in csDMARD-IR and bDMARD-IR RA patients.

Conclusions

This systematic review provides latest evidence for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for RA management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritis, RheumatoidPractice Guidelines as TopicRheumatologyHumansJapanMethotrexateTreatment Outcome

Stichwörter der Autor:innen

Clinical practice guidelinesmeta-analysisozoralizumabrheumatoid arthritissystematic review

Substanzen

Antirheumatic AgentsMethotrexate

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Pharmacology, National Defense Medical College, Tokorozawa, Japan.
  • Department of Rheumatology and Nephrology, Japanese Red Cross Maebashi Hospital, Maebashi, Japan.
  • Department of Emergency and General Medicine, Kyorin University School of Medicine, Tokyo, Japan.
  • The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Yoichi Nakayama, Masayoshi Harigai

Zitieren

APA

Nakayama, Y., Nagata, W., Takeuchi, Y., Fukui, S., Fujita, Y., Hosokawa, Y., Ueno, M., Ono, K., Sumitomo, S., Tabuchi, Y., Nakanishi, Y., Saito, S., Ikeuchi, H., Kawamori, K., Sofue, H., Doi, G., Minami, R., Hirota, T., Minegishi, K., …, & Harigai, M. (2024). Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae049

Vancouver

Nakayama Y, Nagata W, Takeuchi Y, Fukui S, Fujita Y, Hosokawa Y, et al. Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern Rheumatology. 2024. doi:10.1093/mr/roae049

BibTeX
@article{Nakayama2024,
  author = {Nakayama, Yoichi and Nagata, Wataru and Takeuchi, Yoichi and Fukui, Sho and Fujita, Yuya and Hosokawa, Yohei and Ueno, Masanobu and Ono, Kumiko and Sumitomo, Shuji and Tabuchi, Yuya and Nakanishi, Yuichiro and Saito, Shuntaro and Ikeuchi, Hiroko and Kawamori, Kazutaka and Sofue, Hideaki and Doi, Goro and Minami, Runa and Hirota, Tomoya and Minegishi, Kaoru and Maeshima, Keisuke and Motoyama, Ryo and Nakamura, Shohei and Suzuki, Shotaro and Nishioka, Norihiro and Wada, Takuma Tsuzuki and Onishi, Akira and Nishimura, Kenichi and Watanabe, Ryu and Yanai, Ryo and Kida, Takashi and Nishiwaki, Hiroki and Yajima, Nobuyuki and Kaneko, Yuko and Tanaka, Eiichi and Kawahito, Yutaka and Harigai, Masayoshi},
  title = {Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis},
  journal = {Modern Rheumatology},
  year = {2024},
  doi = {10.1093/mr/roae049}
}
Kostenlos starten →